Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
Journal article
Hamdy FC. et al, (2023), New England Journal of Medicine
Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment
Journal article
Donovan JL. et al, (2023), NEJM Evidence
Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survival.
Journal article
Whitburn J. et al, (2022), Sci Adv, 8
Local anaesthetic transperineal (LATP) prostate biopsy using a probe-mounted transperineal access system: a multicentre prospective outcome analysis.
Journal article
Lopez JF. et al, (2021), BJU Int, 128, 311 - 318
Placebo comparator group selection and use in surgical trials: the ASPIRE project including expert workshop.
Journal article
Beard DJ. et al, (2021), Health Technol Assess, 25, 1 - 52
Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer.
Journal article
Sjoberg HT. et al, (2021), Br J Cancer, 125, 534 - 546
Applying Surgical Placebo in Randomised Evaluations (ASPIRE) - methods and recommendations for placebo comparator group selection and use in surgical trials
Journal article
BEARD D. et al, (2021), NIHR Journals Library
A Systematic Review of Prostate Cancer Heterogeneity: Understanding the Clonal Ancestry of Multifocal Disease.
Journal article
Erickson A. et al, (2021), Eur Urol Oncol, 4, 358 - 369
Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment: A Systematic Review.
Journal article
Farolfi A. et al, (2021), Eur Urol Oncol
Use of intraoperative fluorescence to enhance robot-assisted radical prostatectomy.
Journal article
Rajakumar T. et al, (2021), Future Oncol, 17, 1083 - 1095
Polygenic hazard score is associated with prostate cancer in multi-ethnic populations.
Journal article
Huynh-Le M-P. et al, (2021), Nat Commun, 12
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.
Journal article
Conti DV. et al, (2021), Nat Genet, 53, 65 - 75
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples.
Journal article
Bailey MH. et al, (2020), Nat Commun, 11
Outreach and Influence of Surgical Societies' Recommendations on Minimally Invasive Surgery During the COVID-19 Pandemic-An Anonymized International Urologic Expert Inquiry.
Journal article
Boehm K. et al, (2020), Urology, 145, 73 - 78
Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial.
Journal article
Sanghera S. et al, (2020), BMC Cancer, 20
The effect of sample size on polygenic hazard models for prostate cancer.
Journal article
Karunamuni RA. et al, (2020), Eur J Hum Genet, 28, 1467 - 1475
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples.
Journal article
Bailey MH. et al, (2020), Nat Commun, 11
A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data.
Journal article
Huynh-Le M-P. et al, (2020), Cancer Epidemiol Biomarkers Prev, 29, 1731 - 1738